Cell Therapy News Volume 25.12 | Apr 22 2024

    0
    9








    2024-04-22 | CTN 25.14


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.14 – 22 April, 2024
    TOP STORY

    A Novel Engineered IL-21 Receptor Arms T-Cell Receptor-Engineered T Cells (TCR-T Cells) against Hepatocellular Carcinoma

    Researchers determined the combination effects of IL-21 in T cell therapy against HCC and investigate optimized strategies to utilize the effect of IL-21 signal in T cell therapy.
    [Signal Transduction And Targeted Therapy]

    Full Article
    Tools to isolate, culture, and assay cells. Click to explore.
    PUBLICATIONSRanked by the impact factor of the journal

    Bispecific CAR T Cell Therapy Targeting BCMA and CD19 in Relapsed/Refractory Multiple Myeloma: A Phase I/II Trial

    Scientists designed bispecific BC19 CAR T cells targeting BCMA/CD19 and evaluated antimyeloma activity in vitro and in vivo. Preclinical results indicated that BC19 CAR specifically recognized target antigens, and BC19 CAR T cells mediate selective killing of BCMA or CD19-positive cancer cells.
    [Nature Communications]

    Full Article

    Cellular Trojan Horse Initiates Bimetallic Fe-Cu MOF-Mediated Synergistic Cuproptosis and Ferroptosis against Malignancies

    Investigators engineered a Cellular Trojan Horse, named MetaCell, which used live neutrophils to stably internalize thermosensitive liposomal bimetallic Fe-Cu MOFs. MetaCell could instigate cuproptosis and ferroptosis, thereby enhancing treatment efficacy.
    [Science Advances]

    Full Article

    USP8-Governed GPX4 Homeostasis Orchestrates Ferroptosis and Cancer Immunotherapy

    Investigators reported that homozygous deletion of ubiquitin-specific protease 8 (Usp8) in intestinal epithelial cells (IEC) led to architectural changes in the colonic epithelium and shortens mouse lifespan accompanied by increased IEC death and signs of lipid peroxidation.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Phase I Study Combining Elotuzumab with Autologous Stem Cell Transplant and Lenalidomide for Multiple Myeloma

    The authors conducted a Phase I clinical trial to investigate the application of autologous lymphocyte infusion and anti-SLAMF7 monoclonal antibody, elotuzumab, after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma previously treated with induction therapy.
    [Journal For Immunotherapy Of Cancer]

    Abstract

    Oncolytic Herpes Simplex Virus Expressing IL-2 Controls Glioblastoma Growth and Improves Survival

    The authors developed G47Δ-mIL2 using the flip-flop herpes simplex virus BAC system to deliver IL-2 locally within the tumor microenvironment (TME). They then tested its efficacy in orthotopic mouse GBM models and evaluated immune profiles in the treated tumors and spleens by flow cytometry and immunohistochemistry.
    [Journal For Immunotherapy Of Cancer]

    Abstract

    Self-Adjuvanting Polymeric Nanovaccines Enhance IFN Production and Cytotoxic T Cell Response

    Researchers reported a novel subunit vaccine delivery platform constructed via in situ free radical polymerization of C7A (2-(Hexamethyleneimino) ethyl methacrylate) and acrylamide around the surface of individual protein antigens.
    [Journal Of Controlled Release]

    AbstractGraphical Abstract

    Characterization of a Novel T Cell-Engaging Bispecific Antibody for Elimination of L1CAM-Positive Tumors

    Scientists designed and characterized a novel bispecific antibody based on the IgG-(L)-ScFv format, which targeted L1CAM and CD3 simultaneously.
    [Biomedicine & Pharmacotherapy]

    Full Article

    Single-Cell Sequencing Reveals VEGFR as a Potential Target for CAR-T Cell Therapy in Chordoma

    14 chordoma samples from patients attending Xuanwu Hospital Capital Medical University were subjected to single-cell RNA sequencing. Target molecules were identified on chordoma cells and cancer metastasis-related signaling pathways characterised.
    [Journal Of Orthopaedic Translation]

    Abstract
    Win a Hippocampus Print! Sign up for the StainsFile Newsletter to enter the draw.
    REVIEWS

    Role of FoxP3+ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy

    Regulatory T cells are crucial for maintaining tolerance against self or nonself antigens. Of importance, Tregs also play an important role in dampening immune responses to AAV gene therapy, including tolerance induction to the transgene product.
    [Human Gene Therapy]

    Abstract

    From Spear to Trident: Upgrading Arsenal of CAR-T Cells in the Treatment of Multiple Myeloma

    The authors provide an overview of the new advances of CAR-T cells in the cure of multiple myeloma (MM), and look at the progress of the clinical use of CAR-T cells in MM to try to provide a reference for their clinical use when managing MM.
    [Heliyon]

    Full Article
    INDUSTRY AND POLICY NEWS

    Monash Cord Blood Cell Therapy Research Recognised with Multiple Awards

    Congratulations to Dr. Lindsay Zhou on receiving the Perinatal Research Society Mont Liggins Award and the Cerebral Palsy Alliance Award from the Perinatal Society of Australia and New Zealand for his research on cord blood cell therapy.
    [Monash University]

    Full Article

    French-Canadian Gets ‘Oscars Of Science’ Prize For Cancer Treatment

    French-Canadian scientist Michel Sadelain was awarded an “Oscars of Science” prize in Los Angeles for his research into genetically modifying immune cells to fight cancer.
    [Barron’s]

    Press Release
    FEATURED EVENT

    Brain Tumor Meeting 2024

    May 23 – 24, 2024
    Berlin, Germany

    > See All Events

    JOB OPPORTUNITIES

    Scientist – In Vivo Cell Therapy

    AstraZeneca – Cambridge, England, United Kingdom

    Research Technician – CAR T Cell Therapy

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Scholar – Synthetic Extracellular Matrix

    University of Oregon – Eugene, Oregon, United States

    PhD Scholarship – Regulatory T Cell Therapy for Inflammatory Bowel Disease

    Monash University – Melbourne, Victoria, Australia

    Associate Director – Stravitz-Sanyal Institute for Liver Disease

    Virginia Commonwealth University – Richmond, Virginia, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2